ImmunosuppressionPostoperative ComplicationsImmunosuppressive AgentsImmune ToleranceGraft RejectionTacrolimusKidney TransplantationTreatment OutcomeCyclosporineGraft SurvivalRetrospective StudiesLiver TransplantationAzathioprineTransplantation, HomologousMycophenolic AcidIntraoperative ComplicationsTime FactorsImmunocompromised HostAntilymphocyte SerumFollow-Up StudiesOrgan TransplantationRisk FactorsProspective StudiesHeart TransplantationPancreas TransplantationDiabetes ComplicationsTransplantation ImmunologyT-LymphocytesCalcineurinReoperationIslets of Langerhans TransplantationSpleenPregnancy ComplicationsRecurrenceLymphoproliferative DisordersIncidenceTissue DonorsTransplantation ToleranceAdrenal Cortex HormonesSirolimusDrug Therapy, CombinationLymphocyte ActivationTransplantationMethylprednisoloneAcute DiseaseOpportunistic InfectionsMuromonab-CD3Living DonorsMice, Inbred C57BLMice, Inbred BALB CFatal OutcomeCyclosporinsBiopsyPostoperative CareT-Lymphocytes, RegulatoryPrednisonePolyomavirus InfectionsUltraviolet RaysInfectionLung TransplantationImmunocompetenceRisk AssessmentSurvival RateAntibodies, MonoclonalDiabetes Mellitus, Type 1Tomography, X-Ray ComputedSteroidsAntibody FormationLymphocytesHemorrhageLength of StayDermatitis, ContactPrednisoloneGraft vs Host DiseaseImmune SystemBone Marrow TransplantationBK VirusObstetric Labor ComplicationsPregnancyLaparoscopySkin TransplantationSurgical Wound InfectionImmunity, CellularDrainageLiver FailureKidney Failure, ChronicDisease Models, AnimalCytomegalovirus InfectionsCyclophosphamideAnemia, AplasticCohort StudiesEquipment FailureChronic DiseaseSurvival AnalysisTransplantsCadaverDevice RemovalKidneyTransplantation ChimeraPrognosis